One 5-ASA stands out from the crowd so your paediatric UC patients don’t have to
Prescribe PENTASA® for your paediatric* patients because:
PENTASA® demonstrated complete remission* in mild to moderate paediatric UC patients at week 618
The formulations include 1g, 2g and 4g sachets, which may reduce pill burden and encourage patient adherence3-5
89% of paediatric† patients were found to be compliant to therapy at week 6 of a randomised controlled trial18
PENTASA® can be taken independent of food or in yoghurt at any time of the day to fit in with your paediatric patients’ daily routine, making them more convenient than ever1-5
Job Code: UK-PA-2400044 - Date of preparation: November 2024
Our use of cookies
We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.
Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.
Necessary cookies
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics cookies
We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.